News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
261 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21820)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (335)
2 (311)
3 (237)
4 (70)
6 (2)
7 (48)
8 (54)
9 (56)
10 (84)
11 (40)
13 (1)
14 (80)
15 (90)
16 (78)
17 (59)
18 (31)
20 (1)
21 (91)
22 (78)
23 (75)
24 (68)
25 (25)
26 (1)
28 (4)
29 (222)
30 (262)
31 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
26
28
29
30
31
Drug Development
Curis Announces FDA Fast Track Designation for Fimepinostat (CUDC-907) Development in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Curis, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development of fimepinostat in patients with relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy.
May 31, 2018
·
3 min read
Policy
Sarissa Capital Issues Statement On Ironwood Pharmaceuticals
Sarissa Capital Management LP today made the following statement regarding Ironwood Pharmaceuticals, Inc.
May 31, 2018
·
2 min read
Pharm Country
Realm Therapeutics to Present at June 2018 Investor Conferences
Realm Therapeutics plc (AIM: RLM), a clinical stage biopharmaceutical company focused on developing novel therapeutics in immune-mediated diseases, today announces that the Company will participate in several investor conferences in June.
May 31, 2018
·
3 min read
Genetown
AVEO Oncology to Present at the Jefferies 2018 Healthcare Conference
AVEO Oncology announced that Michael Bailey, president and chief executive officer, will present at the Jefferies 2018 Healthcare Conference.
May 31, 2018
·
2 min read
Genetown
Ra Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
Ra Pharmaceuticals, Inc. announced that Doug Treco, Ph.D., President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference.
May 31, 2018
·
1 min read
Business
Concordia International Corp. Provides Corporate Update
Concordia International Corp. announced a number of corporate developments.
May 31, 2018
·
9 min read
Genetown
ArQule to Present at the Jefferies 2018 Healthcare Conference on June 7, 2018
ArQule, Inc. announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, will present at the Jefferies 2018 Healthcare Conference.
May 31, 2018
·
2 min read
BioMidwest
Aerpio Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
Aerpio Pharmaceuticals, Inc. announced that Chief Executive Officer, Stephen Hoffman, M.D., Ph.D., will present at the Jefferies 2018 Global Healthcare Conference.
May 31, 2018
·
1 min read
Business
Glassbeam Adds Calamed as New Healthcare Service Partner for the Caribbean and Latin America
Glassbeam, Inc announced that Calamed LLC has become a strategic reseller of Glassbeam solutions.
May 31, 2018
·
3 min read
Bio NC
Aerie Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
Aerie Pharmaceuticals, Inc. announced that Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference.
May 31, 2018
·
2 min read
Previous
5 of 27
Next